Progression of Spinal Fusion in Ankylosing Spondylitis
2 other identifiers
observational
63
1 country
1
Brief Summary
This study will evaluate: 1) whether computed tomography (CT) scanning is better than regular x-rays for measuring changes in the stiffness, or fusion, of the spine in patients with ankylosing spondylitis; and 2) if CT can be used to determine how fast extra bone forms in the spine of these patients. Better ways to measure spinal fusion are needed to be able to evaluate the effectiveness of medicines in slowing or stopping its progression. CT uses x-rays to provide detailed pictures of the inside of the body and are valuable for detecting spinal abnormalities because of the precision with which it can show these structures. For the procedure, the patient lies on a table that moves into a large, donut-shaped scanner that can move around the body to take pictures at different angles, which are viewed on a computer monitor. Patients 18 years of age and older with ankylosing spondylitis who are not currently taking or planning to receive treatment with anti-TNF alpha medications (etanercept, infliximab, adalimumab) for 1 year may be eligible for this study. Participants have eight clinic visits, scheduled at study entry and at 4, 8, 12, 16, 20, 24, and 48 months, at the NIH Clinical Center for the following procedures:
- Clinical assessment (all visits) - includes medical history and physical examination, measurement of spine flexibility with a tape measure and protractor, symptoms questionnaire
- Blood tests for measures of inflammation, including red blood cell sedimentation rate and C-reactive protein level (all visits)
- Urine pregnancy test in women of child-bearing age (visits 1, 4, 7, 8)
- X-rays of the pelvis, low back, and neck (visits 1, 4, 7)
- X-ray of the low back (visit 8)
- CT scan of the low back (visits 1, 4, 7)
- Magnetic resonance imaging (MRI) of the low back (visits 1, 4) - MRI combines a powerful magnet with an advanced computer system and radio waves to produce accurate, detailed pictures of organs and tissues. The patient lies on a table in a narrow cylinder containing a magnetic field, wearing earplugs to muffle loud noises that occur with electrical switching of the magnetic fields. He or she can speak with a staff member via an intercom system at all times during the procedure. During the scan, a contrast dye (gadolinium) is injected into the bloodstream through a catheter (plastic tube inserted in a vein) to brighten the images. In addition, participants will complete a symptoms questionnaire by mail every 4 months for 2 years between visits 7 and 8.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2004
CompletedFirst Posted
Study publicly available on registry
June 21, 2004
CompletedStudy Start
First participant enrolled
December 3, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2021
CompletedApril 16, 2026
April 1, 2026
14.9 years
June 18, 2004
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Syndesmophyte growth
syndesmophyte growth by CT
1 and 2 years
Eligibility Criteria
clinical sample
You may qualify if:
- Age 18 years or older
- Diagnosis of AS by the modified New York criteria
- Lumbar spine BASRI score of 0, 1, 2, or 3
- We will aim to recruit at least 6 patients in each of the following BASRI lumbar spine categories:
- or 1 (normal or suspicious changes)
- (erosions, sclerosis or squaring with or without syndesmophytes or 2 or fewer vertebrae)
- (syndesmophytes on 3 or more vertebrae with fusion of at most 2 vertebrae)
You may not qualify if:
- Inability to provide informed consent.
- BASRI lumbar spine score of 4 (complete fusion; 12)
- Contraindication to MRI scanning based on the NMR Center MRI Safety Screening Questionnaire or size or weight limitations of the scanner.
- History of allergic reactions to gadolinium-DPTA contrast used for MRI
- Anticipated unavailability for follow-up over 2 years
- Pregnancy
- Onset of AS at age 16 or younger
- Spondyloarthropathy other than AS
- Severe scoliosis or other spinal malalignment that would complicate scan interpretation
- B. CROSS-SECTIONAL (RELIABILITY) STUDY PROTOCOL
- Up to 35 patients will be studied.
- Age 18 years or older
- Diagnosis of AS by the modified New York criteria (5)
- Inability to provide informed consent
- BASRI lumbar spine score of 4 (complete fusion)\<TAB\>
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (3)
Keaveny TM. Biomechanical computed tomography-noninvasive bone strength analysis using clinical computed tomography scans. Ann N Y Acad Sci. 2010 Mar;1192:57-65. doi: 10.1111/j.1749-6632.2009.05348.x.
PMID: 20392218BACKGROUNDSimkin PA, Downey DJ, Kilcoyne RF. Apophyseal arthritis limits lumbar motion in patients with ankylosing spondylitis. Arthritis Rheum. 1988 Jun;31(6):798-802. doi: 10.1002/art.1780310617.
PMID: 3382452BACKGROUNDCann CE, Genant HK, Kolb FO, Ettinger B. Quantitative computed tomography for prediction of vertebral fracture risk. Bone. 1985;6(1):1-7. doi: 10.1016/8756-3282(85)90399-0.
PMID: 3994856BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert A Colbert, M.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2004
First Posted
June 21, 2004
Study Start
December 3, 2004
Primary Completion
October 18, 2019
Study Completion
February 13, 2021
Last Updated
April 16, 2026
Record last verified: 2026-04